NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Seattle businesses have posted about plans to take part in the nationwide protest, with participation ranging from closure to donating proceeds to nonprofits.Read More